Stonebridge Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Stonebridge Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-60	Closed	-$7.34K	–	487
2023 Q3	$7.34K	Sell	60 -5	-8%	-$636	﹤0.01%	653
2023 Q2	$8.25K	Buy	65 +5	+8%	+$650	﹤0.01%	639
2023 Q1	$7.75K	Hold	60	–	–	﹤0.01%	651
2022 Q4	$7.88K	Hold	60	–	–	﹤0.01%	641
2022 Q3	$7K	Sell	60 -50	-45%	-$6.21K	﹤0.01%	639
2022 Q2	$13K	Hold	110	–	–	﹤0.01%	552
2022 Q1	$14K	Hold	110	–	–	﹤0.01%	601
2021 Q4	$17K	Hold	110	–	–	﹤0.01%	535
2021 Q3	$18K	Sell	110 -94	-46%	-$15.8K	﹤0.01%	515
2021 Q2	$33K	Buy	204 +144	+240%	+$22.2K	﹤0.01%	544
2021 Q1	$9K	Buy	+60	New	+$9.53K	﹤0.01%	652
2020 Q3	–	Sell	-102	Closed	-$14K	–	407
2020 Q2	$14K	Hold	102	–	–	﹤0.01%	449
2020 Q1	$11K	Hold	102	–	–	﹤0.01%	465
2019 Q4	$12K	Buy	102 +42	+70%	+$4.69K	﹤0.01%	530
2019 Q3	$6K	Hold	60	–	–	﹤0.01%	596
2019 Q2	$7K	Buy	+60	New	+$6.38K	﹤0.01%	622

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Stonebridge Capital Advisors's IBB Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 60 shares — an estimated $7.34K sold.

Stonebridge Capital Advisors first reported a position in IBB in Q2 2019 and held it in 16 quarters. The position peaked at $33K in Q2 2021. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

Stonebridge Capital Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
Stonebridge Capital Advisors sold 60 iShares Biotechnology ETF shares in Q4 2023, an estimated $7.34K.
Stonebridge Capital Advisors first reported a position in iShares Biotechnology ETF in Q2 2019 and held it in 16 quarters.
Stonebridge Capital Advisors's iShares Biotechnology ETF position peaked at $33K in Q2 2021.
872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.